An observational study of COVID-19 vaccine safety of a pharmacovigilance unit in a third level hospital in Barcelona, Spain
Latest Information Update: 19 Aug 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 19 Aug 2022 New trial record
- 28 Jun 2022 Results presented at the 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) 2022